Medical Oncology

Uzm. Dr. Mustafa Emre Duygulu

Doctor and researcher Erol Olçok Eğitim ve Araştırma Hastanesi Çorum
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionErol Olçok Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications22 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-5113-6782ORCIDFrom source
  • Last synchronised5 November 2026 10:36https://corumeah.saglik.gov.tr/TR-1439906/doktorlarimiz.html#mustafa-emre-duygulusaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

22 publications
Publications by year Most: 9, in 2026
  1. 2016: 1 publication
  2. 2017: 0 publications
  3. 2018: 0 publications
  4. 2019: 0 publications
  5. 2020: 0 publications
  6. 2021: 2 publications
  7. 2022: 0 publications
  8. 2023: 1 publication
  9. 2024: 5 publications
  10. 2025: 4 publications
  11. 2026: 9 publications

  1. Meme Kanseri

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852 Open-access full textSource: OpenAlex

  2. The 100 most cited articles in ESR1 mutant breast cancer: a bibliometric analysis

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1842275 Open-access full textSource: ORCID

  3. Prognostic Significance of the Systemic Immune-Inflammation Index and Pan-Immune-Inflammation Value in Metastatic Soft Tissue Sarcoma

    Hitit Medical Journal, 2026

    DOI 10.52827/hititmedj.1657483 Open-access full textSource: ORCID

  4. Retrospective analysis of tumor spread through air spaces (STAS) in non-small cell lung cancer (NSCLC) cases

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1783967 Open-access full textSource: ORCID

  5. Metastatik Meme Kanserinde Kemik Metastazlarına Yaklaşım

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852.c2783 Source: ORCID

  6. Prognostic Impact of RAS and TP53 Mutation Profiles in Metastatic Colorectal Cancer

    Medicina, 2026

    DOI 10.3390/medicina62010136 PMID 41597425 Open-access full textSource: ORCID

  7. Modified Glasgow Prognostic Score is Associated with Prognosis in Older Adult Patients with Metastatic Melanoma

    European Journal of Geriatrics and Gerontology, 2026

    DOI 10.4274/ejgg.galenos.2025.2025-3-7 Open-access full textSource: OpenAlex

  8. Association Between Dermatologic Manifestations of Ulcerative Colitis and Serum Activin-A Levels

    Endoscopy, 2026

    DOI 10.1055/s-0046-1822077 Source: OpenAlex

  9. Relationship Between Dermatological Involvement in Ulcerative Colitis and Serum Activin-A Levels

    DergiPark (Istanbul University), 2026

    DOI 10.71051/jnlm.1881476 Open-access full textSource: OpenAlex

  10. A Comparison of the Flow Cytometric Analysis Results of Benign and Malignant Serous Tumors of the Ovary

    Cancers, 2025

    DOI 10.3390/cancers17162691 PMID 40867320 1 citation (Europe PMC) Open-access full textSource: ORCID

View all 22 publications